Pieris Pharmaceuticals, Inc. (PIRS): Price and Financial Metrics
Pieris Pharmaceuticals, Inc. (PIRS)
Today's Latest Price: $3.48 USD
0.12 (-3.33%)
Updated Jun 1 6:55pm
Add PIRS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
PIRS Stock Summary
- Of note is the ratio of Pieris Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; just 12.97% of US stocks have a lower such ratio.
- The ratio of debt to operating expenses for Pieris Pharmaceuticals Inc is higher than it is for about merely 18.88% of US stocks.
- Revenue growth over the past 12 months for Pieris Pharmaceuticals Inc comes in at 52.25%, a number that bests 90.02% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Pieris Pharmaceuticals Inc are CDTX, MGEN, WVE, SYBX, and UMRX.
- Visit PIRS's SEC page to see the company's official filings. To visit the company's web site, go to www.pieris.com.
PIRS Daily Price Range
PIRS 52-Week Price Range
PIRS Stock Price Chart More Charts
PIRS Price/Volume Stats
| Current price | $3.48 | 52-week high | $6.04 |
| Prev. close | $3.60 | 52-week low | $1.60 |
| Day low | $3.30 | Volume | 573,900 |
| Day high | $3.59 | Avg. volume | 474,977 |
| 50-day MA | $2.67 | Dividend yield | N/A |
| 200-day MA | $3.44 | Market Cap | 182.08M |
Pieris Pharmaceuticals, Inc. (PIRS) Company Bio
Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops Anticalin-based drugs. The company develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. The company is based in Boston, Massachusetts.
Loading social stream, please wait...